Compare $APYX vs $HYPR | Chartloom

Compare

$APYX vs $HYPR

Apyx Medical Inc · Hyperfine Inc

APYX

Apyx Medical Inc

HYPR

Hyperfine Inc

Compare $APYX vs $HYPR

Comparing Apyx Medical Inc and Hyperfine Inc

APYXApyx Medical Inc

HYPRHyperfine Inc

APYXApyx Medical Inc

Market cap

$109M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

1.73x

Rev growth (TTM)

25.6%

YTD performance

-26.0%

52W performance

-9.8%

FCF yield

-10.2%

HYPRHyperfine Inc

Market cap

$92M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

3.92x

Rev growth (TTM)

53.2%

YTD performance

-3.9%

52W performance

-55.5%

FCF yield

-29.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

APYX

HYPR

Detailed metrics comparison

APYX

Apyx Medical Inc

HYPR

Hyperfine Inc

Market Cap

APYX$109M

HYPR$92M

Enterprise Value

APYX$116M

HYPR$62M

Price

APYX$2.59

HYPR$0.93

P/E Ratio

APYXN/A

HYPRN/A

P/S Ratio

APYX1.86x

HYPR5.59x

EV/Sales

APYX1.99x

HYPR3.76x

EV/EBITDA

APYX166.88x

HYPR0.00x

P/B Ratio

APYX10.07x

HYPR2.58x

P/FCF Ratio

APYXN/A

HYPRN/A

EV/FCF

APYX-10.53x

HYPR-2.26x

PEG Ratio

APYXN/A

HYPRN/A

Forward P/E (NTM)

APYXN/A

HYPRN/A

Forward P/S (NTM)

APYX1.73x

HYPR3.92x

Revenue (TTM)

APYX$58M

HYPR$17M

Revenue Growth (YoY)

APYX25.6%

HYPR53.2%

Forward Rev Growth

APYX11.1%

HYPR30.2%

Gross Margin (TTM)

APYX63.5%

HYPR51.4%

Operating Margin (TTM)

APYX0.0%

HYPR0.0%

EBITDA Margin (TTM)

APYX-4.7%

HYPR-196.5%

Net Margin (TTM)

APYX-14.8%

HYPR-210.8%

FCF Margin (TTM)

APYX-18.9%

HYPR-166.5%

Net Income (TTM)

APYX$-9M

HYPR$-35M

FCF (TTM)

APYX$-11M

HYPR$-28M

EPS (TTM)

APYX-$0.20

HYPR-$0.35

ROE (TTM)

APYX-7870.0%

HYPR-10030.0%

ROA (TTM)

APYX-1391.0%

HYPR-6334.0%

ROIC (TTM)

APYX-1878.0%

HYPR-8431.0%

Cash

APYX$28M

HYPR$43M

Debt

APYX$35M

HYPR$13M

Net Cash/Debt

APYX$-8M

HYPR$30M

Current Ratio (TTM)

APYX5.68x

HYPR6.15x

Quick Ratio (TTM)

APYX4.41x

HYPR5.25x

Debt/Equity (TTM)

APYX3.32x

HYPR0.36x

Debt/Assets (TTM)

APYX0.0%

HYPR0.0%

Interest Coverage (TTM)

APYXN/A

HYPRN/A

Net Debt/EBITDA (TTM)

APYX0.00x

HYPR0.00x

Beta

APYX1.53

HYPR1.51

52W Performance

APYX-9.8%

HYPR-55.5%

YTD Performance

APYX-26.0%

HYPR-3.9%

% from 52W High

APYX-49.0%

HYPR-58.1%

% from 52W Low

APYX11.6%

HYPR23.5%

Asset Turnover (TTM)

APYX0.94x

HYPR0.30x

FCF Yield (TTM)

APYX-10.2%

HYPR-29.8%

Earnings Yield (TTM)

APYX-8.0%

HYPR-37.7%

Dividend Yield (TTM)

APYXN/A

HYPRN/A

Rule of 40

APYX6.7

HYPR-113.3

EV/GP/RG

APYX0.41

HYPR0.17

Ticker research

View APYX research View HYPR research

Metric	APYX Apyx Medical Inc	HYPR Hyperfine Inc
Market & Valuation
Market Cap	$109M	$92M
Enterprise Value	$116M	$62M
Price	$2.59	$0.93
P/E Ratio	N/A	N/A
P/S Ratio	1.86x	5.59x
EV/Sales	1.99x	3.76x
EV/EBITDA	166.88x	0.00x
P/B Ratio	10.07x	2.58x
P/FCF Ratio	N/A	N/A
EV/FCF	-10.53x	-2.26x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	1.73x	3.92x
Revenue & Growth
Revenue (TTM)	$58M	$17M
Revenue Growth (YoY)	25.6%	53.2%
Forward Rev Growth	11.1%	30.2%
Profitability
Gross Margin (TTM)	63.5%	51.4%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-4.7%	-196.5%
Net Margin (TTM)	-14.8%	-210.8%
FCF Margin (TTM)	-18.9%	-166.5%
Net Income (TTM)	$-9M	$-35M
FCF (TTM)	$-11M	$-28M
EPS (TTM)	-$0.20	-$0.35
ROE (TTM)	-7870.0%	-10030.0%
ROA (TTM)	-1391.0%	-6334.0%
ROIC (TTM)	-1878.0%	-8431.0%
Financial Health
Cash	$28M	$43M
Debt	$35M	$13M
Net Cash/Debt	$-8M	$30M
Current Ratio (TTM)	5.68x	6.15x
Quick Ratio (TTM)	4.41x	5.25x
Debt/Equity (TTM)	3.32x	0.36x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.53	1.51
52W Performance	-9.8%	-55.5%
YTD Performance	-26.0%	-3.9%
% from 52W High	-49.0%	-58.1%
% from 52W Low	11.6%	23.5%
Efficiency & Yields
Asset Turnover (TTM)	0.94x	0.30x
FCF Yield (TTM)	-10.2%	-29.8%
Earnings Yield (TTM)	-8.0%	-37.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	6.7	-113.3
EV/GP/RG	0.41	0.17
Ticker research	View APYX research	View HYPR research

Valuation

P/S Ratio

APYX

1.86x

HYPR

5.59x

EV/FCF

APYX

-10.53x

HYPR

-2.26x

Growth & revenue

Revenue Growth TTM

HYPR

53.2%

APYX

25.6%

Forward Revenue Growth

HYPR

30.2%

APYX

11.1%

Profitability & performance

Gross Margin

APYX

63.5%

HYPR

51.4%

ROE

APYX

-7870.0%

HYPR

-10030.0%

FCF Yield %

APYX

-10.2%

HYPR

-29.8%

52-Week Performance

APYX

-9.8%

HYPR

-55.5%

Detailed metrics comparison

APYX

Apyx Medical Inc

HYPR

Hyperfine Inc

Market Cap

APYX$109M

HYPR$92M

Enterprise Value

APYX$116M

HYPR$62M

Price

APYX$2.59

HYPR$0.93

P/E Ratio

APYXN/A

HYPRN/A

P/S Ratio

APYX1.86x

HYPR5.59x

EV/Sales

APYX1.99x

HYPR3.76x

EV/EBITDA

APYX166.88x

HYPR0.00x

P/B Ratio

APYX10.07x

HYPR2.58x

P/FCF Ratio

APYXN/A

HYPRN/A

EV/FCF

APYX-10.53x

HYPR-2.26x

PEG Ratio

APYXN/A

HYPRN/A

Forward P/E (NTM)

APYXN/A

HYPRN/A

Forward P/S (NTM)

APYX1.73x

HYPR3.92x

Revenue (TTM)

APYX$58M

HYPR$17M

Revenue Growth (YoY)

APYX25.6%

HYPR53.2%

Forward Rev Growth

APYX11.1%

HYPR30.2%

Gross Margin (TTM)

APYX63.5%

HYPR51.4%

Operating Margin (TTM)

APYX0.0%

HYPR0.0%

EBITDA Margin (TTM)

APYX-4.7%

HYPR-196.5%

Net Margin (TTM)

APYX-14.8%

HYPR-210.8%

FCF Margin (TTM)

APYX-18.9%

HYPR-166.5%

Net Income (TTM)

APYX$-9M

HYPR$-35M

FCF (TTM)

APYX$-11M

HYPR$-28M

EPS (TTM)

APYX-$0.20

HYPR-$0.35

ROE (TTM)

APYX-7870.0%

HYPR-10030.0%

ROA (TTM)

APYX-1391.0%

HYPR-6334.0%

ROIC (TTM)

APYX-1878.0%

HYPR-8431.0%

Cash

APYX$28M

HYPR$43M

Debt

APYX$35M

HYPR$13M

Net Cash/Debt

APYX$-8M

HYPR$30M

Current Ratio (TTM)

APYX5.68x

HYPR6.15x

Quick Ratio (TTM)

APYX4.41x

HYPR5.25x

Debt/Equity (TTM)

APYX3.32x

HYPR0.36x

Debt/Assets (TTM)

APYX0.0%

HYPR0.0%

Interest Coverage (TTM)

APYXN/A

HYPRN/A

Net Debt/EBITDA (TTM)

APYX0.00x

HYPR0.00x

Beta

APYX1.53

HYPR1.51

52W Performance

APYX-9.8%

HYPR-55.5%

YTD Performance

APYX-26.0%

HYPR-3.9%

% from 52W High

APYX-49.0%

HYPR-58.1%

% from 52W Low

APYX11.6%

HYPR23.5%

Asset Turnover (TTM)

APYX0.94x

HYPR0.30x

FCF Yield (TTM)

APYX-10.2%

HYPR-29.8%

Earnings Yield (TTM)

APYX-8.0%

HYPR-37.7%

Dividend Yield (TTM)

APYXN/A

HYPRN/A

Rule of 40

APYX6.7

HYPR-113.3

EV/GP/RG

APYX0.41

HYPR0.17

Ticker research

View APYX research View HYPR research

Metric	APYX Apyx Medical Inc	HYPR Hyperfine Inc
Market & Valuation
Market Cap	$109M	$92M
Enterprise Value	$116M	$62M
Price	$2.59	$0.93
P/E Ratio	N/A	N/A
P/S Ratio	1.86x	5.59x
EV/Sales	1.99x	3.76x
EV/EBITDA	166.88x	0.00x
P/B Ratio	10.07x	2.58x
P/FCF Ratio	N/A	N/A
EV/FCF	-10.53x	-2.26x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	1.73x	3.92x
Revenue & Growth
Revenue (TTM)	$58M	$17M
Revenue Growth (YoY)	25.6%	53.2%
Forward Rev Growth	11.1%	30.2%
Profitability
Gross Margin (TTM)	63.5%	51.4%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-4.7%	-196.5%
Net Margin (TTM)	-14.8%	-210.8%
FCF Margin (TTM)	-18.9%	-166.5%
Net Income (TTM)	$-9M	$-35M
FCF (TTM)	$-11M	$-28M
EPS (TTM)	-$0.20	-$0.35
ROE (TTM)	-7870.0%	-10030.0%
ROA (TTM)	-1391.0%	-6334.0%
ROIC (TTM)	-1878.0%	-8431.0%
Financial Health
Cash	$28M	$43M
Debt	$35M	$13M
Net Cash/Debt	$-8M	$30M
Current Ratio (TTM)	5.68x	6.15x
Quick Ratio (TTM)	4.41x	5.25x
Debt/Equity (TTM)	3.32x	0.36x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.53	1.51
52W Performance	-9.8%	-55.5%
YTD Performance	-26.0%	-3.9%
% from 52W High	-49.0%	-58.1%
% from 52W Low	11.6%	23.5%
Efficiency & Yields
Asset Turnover (TTM)	0.94x	0.30x
FCF Yield (TTM)	-10.2%	-29.8%
Earnings Yield (TTM)	-8.0%	-37.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	6.7	-113.3
EV/GP/RG	0.41	0.17
Ticker research	View APYX research	View HYPR research